IL5 and asthma: For all such reasons, in severe T2-high asthma, IL-5 represents a pivotal pathogenic factor and a highly valuable target for add-on biological therapies of corticosteroid-resistant, difficult-to-treat eosinophilic phenotypes (Varricchi and Canonica, 2016; Brussino et al., 2018).